Stay updated with breaking news from John Koconis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WARREN, N.J., Nov. 29, 2023 -- Timber Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan...
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (
LEO Pharma has acquired Timber Pharmaceuticals, in a deal that will add an ‘attractive’ late stage asset to its pipeline in medical dermatology, the company said.
WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a...
- Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital...